Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III…

Overview of attention for article published in Oncologist, December 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 13 X users

facebook: 1 Facebook page

Readers on

mendeley: 72 Mendeley

So far, Altmetric has seen 14 X posts from 13 X users, with an upper bound of 114,638 followers.

RT @NatRevClinOncol: At 17% of its planned accrual, E5204 did not meet its primary end point: the addition of bevacizumab to FOLFOX6 in the…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 10 additional X posts.